← Product Code [DQO](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQO) · K024126 # CLEAR OR BRAIDED CONTRAST MEDIA INJECTION LINE OR WITHOUT ROTATOR, CATH LAB KIT (K024126) _Abbott Laboratories · DQO · Jan 14, 2003 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQO/K024126 ## Device Facts - **Applicant:** Abbott Laboratories - **Product Code:** [DQO](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQO.md) - **Decision Date:** Jan 14, 2003 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 870.1200 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular ## Indications for Use High Pressure Tubing (intravascular administration set) intended use Indicated as 10" (or up to 48") CLEAR (or BRAIDED) CONTRAST MEDIA INJECTION LINE WITH ROTATOR, for use in Cardiac catheterization and radiology special procedure ## Device Story High Pressure Tubing is an intravascular administration set used in cardiac catheterization and radiology special procedures. The device serves as a conduit for the delivery of contrast media from an injection system to the patient's intravascular space. It features a rotator for secure connection to catheters. The device is used in clinical settings (e.g., cath labs, radiology suites) by physicians or trained medical staff. It facilitates diagnostic imaging by ensuring reliable, high-pressure delivery of contrast agents, enabling visualization of vascular structures. ## Clinical Evidence Bench testing only. ## Technological Characteristics High pressure tubing (10" to 48" length); clear or braided construction; includes rotator connector; designed for high-pressure contrast media injection; non-electronic; sterile. ## Regulatory Identification An intravascular diagnostic catheter is a device used to record intracardiac pressures, to sample blood, and to introduce substances into the heart and vessels. Included in this generic device are right-heart catheters, left-heart catheters, and angiographic catheters, among others. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wings. The eagle is facing left. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ### JAN 1 4 2003 Abbott Laboratories Hospital Products Division Ms. Nicohl R. Wilding Specialist, Device Registration D-389, Bldg. AP30 200 Abbott Park Road Abbott Park, IL 60064-6157 Re: K024126 > Trade/Device Name: High Pressure Tubing Regulation Number: 21 CFR 870.1200 Regulation Name: Diagnostic intravascular catheter Regulatory Class: Class II Product Code: 74 DQO Dated: December 13, 2002 Received: December 16, 2002 Dear Ms. Wilding: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must {1}------------------------------------------------ Page 2 – Ms. Nicohl R. Wilding comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4586. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html. Sincerely yours, \$\lambda\$ Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ #### Attachment II # K024126 ## Indications for Use Statement | 510(k) Number (if known) | | |--------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Name: | High Pressure Tubing (intravascular administration set) | | Indications For Use: | High Pressure Tubing (intravascular administration set) intended use
Indicated as 10" (or up to 48") CLEAR (or BRAIDED) CONTRAST MEDIA
INJECTION LINE WITH ROTATOR, for use in Cardiac catheterization
and radiology special procedure | # PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE : : : : : : : : : and the comments of the comments of : IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) |--|--| (Division Sign-Off) Division of Cardiovascular Devices | 510(k) Number | K024126 | |---------------|---------| |---------------|---------| | Prescription Use
(per 21 CFR 801.109) | OR Over-The Counter Use | |------------------------------------------|-------------------------| |------------------------------------------|-------------------------| --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQO/K024126](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQO/K024126) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com